Valuation: Bayer AG

Market Cap 48.02B 83,156B 54.53B 45.5B 41.08B 77.42B 5,229B 78.42B 544B 209B 2,673B 205B 200B 8,570B P/E 2026 *
22.2x
P/E 2027 * 15.9x
Enterprise Value 77.98B 135,030B 88.55B 73.88B 66.7B 126B 8,490B 127B 884B 340B 4,340B 333B 325B 13,916B EV / Sales 2026 *
1.7x
EV / Sales 2027 * 1.59x
Free-Float
99.99%
Yield 2026 *
0.33%
Yield 2027 * 1.14%
1 day+4.41%
1 week-7.85%
Current month-2.76%
1 month-7.73%
3 months+769.03%
6 months+769.03%
Current year+769.03%
1 week 27,000
Extreme 27000
31,440
1 month 27,000
Extreme 27000
33,000
Current year 26,000
Extreme 26000
33,000
1 year 26,000
Extreme 26000
33,000
3 years 3,323.26
Extreme 3323.263
33,000
5 years 3,323.26
Extreme 3323.263
33,000
10 years 3,323.26
Extreme 3323.263
33,000
Manager TitleAgeSince
Chief Executive Officer 60 2023-05-31
Director of Finance/CFO 57 2026-05-31
Chief Tech/Sci/R&D Officer 59 2021-01-31
Director TitleAgeSince
Director/Board Member 56 2012-03-31
Director/Board Member 61 2017-03-31
Chairman 68 2020-04-27
Change 5-day change 1-year change 3-year change Capi.($)
+4.41%-7.85% - - 54.41B
+0.18%+3.01%+55.39%+120.26% 1,056B
-0.14%-0.72%+44.13%+72.25% 645B
+0.05%-0.57%+13.83%+77.79% 465B
-1.71%-0.82%+74.99%+43.22% 368B
-0.06%-3.88%+34.32%+40.74% 335B
-0.79%+2.01%+19.82%+28.48% 275B
-1.19%-1.21%+9.82%+12.15% 255B
-0.28%+4.35%+50.16%+59.12% 229B
-0.66%-0.68%+35.44%+102.89% 188B
Average +0.04%+0.12%+37.54%+61.88% 423.98B
Weighted average by Cap. -0.23%+0.30%+41.56%+74.19%

Financials

2026 *2027 *
Net sales 45.83B 79,363B 52.04B 43.42B 39.2B 73.89B 4,990B 74.84B 520B 200B 2,551B 195B 191B 8,179B 47.06B 81,495B 53.44B 44.59B 40.25B 75.87B 5,124B 76.85B 533B 205B 2,620B 201B 196B 8,399B
Net income 2.14B 3,706B 2.43B 2.03B 1.83B 3.45B 233B 3.49B 24.26B 9.34B 119B 9.13B 8.93B 382B 2.94B 5,091B 3.34B 2.79B 2.51B 4.74B 320B 4.8B 33.33B 12.83B 164B 12.54B 12.26B 525B
Net Debt 29.96B 51,874B 34.02B 28.38B 25.62B 48.29B 3,262B 48.92B 340B 131B 1,667B 128B 125B 5,346B 26.84B 46,474B 30.48B 25.43B 22.96B 43.27B 2,922B 43.83B 304B 117B 1,494B 114B 112B 4,789B
Logo Bayer AG
Bayer AG is one of the world's leaders in designing, producing, and marketing pharmaceutical products and agrochemicals. Net sales are distributed by product family as follows: - agrochemicals (47.5%): herbicides, fungicides, insecticides, etc.; - pharmaceutical products (39.1%): intended for the prevention and treatment of cardiovascular and respiratory diseases, diabetes, nervous system disorders, etc.; - OTC products and nutritional supplements (12.7%); - other (0.7%). Net sales are distributed geographically as follows: Germany (5.7%), Switzerland (1%), Europe-Middle East-Africa (22.9%), United States (33.1%), North America (3.6%), China (7.6%), Asia-Pacific (8.9%), Brazil (9.6%), and Latin America (7.6%).
Employees
87,830
Date Price Change Volume
26-09-29 ARS 28,880.00 +4.41% 18
26-09-28 ARS 27,660.00 -7.80% 187
26-09-25 ARS 30,000.00 -4.58% 70
26-09-24 ARS 31,440.00 +0.32% 30
26-09-22 ARS 31,340.00 +1.10% 79
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
48.88EUR
Average target price
58.22EUR
Spread / Average Target
+19.11%

Quarterly revenue - Rate of surprise